Geneva, June 22 -- International Clinical Trials Registry received information related to the study (ChiCTR2600126677) titled 'A Real-World Study on the Efficacy and Safety of Different Doses of Amoxicillin Combined with Potassium-Competitive Acid Blockers in Helicobacter Pylori Eradication' on June 13.
Study Type: Observational study
Study Design:
Cohort study
Primary Sponsor: The First Affiliated Hospital of Nanchang University
Condition:
Helicobacter pylori infection
Intervention:
Medium-dose group:None
High-dose group:None
Recruitment Status: Not Recruiting
Phase: N/A
Date of First Enrollment: 2026-06-30
Target Sample Size: Medium-dose group:200;High-dose group:200;Low-dose group:200;
Countries of Recruitment:
China
...